TY - JOUR
T1 - Effectiveness of postoperative intravenous acetaminophen (Acelio) after gastrectomy A propensity score-matched analysis
AU - Ohkura, Yu
AU - Haruta, Shusuke
AU - Shindoh, Junichi
AU - Tanaka, Tsuyoshi
AU - Ueno, Masaki
AU - Udagawa, Harushi
N1 - Publisher Copyright:
Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved.
PY - 2016
Y1 - 2016
N2 - The aim of this study was to investigate the efficacy of postoperative scheduled intravenous acetaminophen to reduce the opioid use and enhance recovery after gastrectomy. Opioid use is reportedly associated with delayed recovery of gastrointestinal (GI) peristalsis and postoperative nausea/vomiting (PONV) despite of acceptable efficacy for pain control. Of 147 and 96 consecutive patients who underwent gastrectomy for gastric cancer before and after introduction of postoperative scheduled intravenous acetaminophen, propensity score matched population was created and short-term clinical outcomes were compared. Significant defervescence was demonstrated in Acetaminophen group (A-group) compared with control group (C-group) during the perioperative period (P<0.001), whereas no significant difference was observed in postoperative inflammatory parameters. The incidence of postoperative complications was similar between the groups. The number of patient-controlled analgesia (PCA) pushes was significantly reduced in the A-group (P=0.007) and the frequency of use of other nonopioid analgesics was also significantly reduced in the A-group (P<0.001). Both daily and cumulative opioid use was significantly reduced in the A-group (P<0.001). The time to first flatus and defecation was decreased in the A-group (P<0.001 and P=0.038, respectively). The incidence of PONV was significantly reduced from 26.0% to 12.5% after introduction of intravenous acetaminophen (P=0.017), and hospital stay tended to be decreased in the A-group (13.2 vs 14.7 days, P=0.069) Postoperative scheduled intravenous acetaminophen decreased opioid use and may be associated with enhanced recovery after gastrectomy.
AB - The aim of this study was to investigate the efficacy of postoperative scheduled intravenous acetaminophen to reduce the opioid use and enhance recovery after gastrectomy. Opioid use is reportedly associated with delayed recovery of gastrointestinal (GI) peristalsis and postoperative nausea/vomiting (PONV) despite of acceptable efficacy for pain control. Of 147 and 96 consecutive patients who underwent gastrectomy for gastric cancer before and after introduction of postoperative scheduled intravenous acetaminophen, propensity score matched population was created and short-term clinical outcomes were compared. Significant defervescence was demonstrated in Acetaminophen group (A-group) compared with control group (C-group) during the perioperative period (P<0.001), whereas no significant difference was observed in postoperative inflammatory parameters. The incidence of postoperative complications was similar between the groups. The number of patient-controlled analgesia (PCA) pushes was significantly reduced in the A-group (P=0.007) and the frequency of use of other nonopioid analgesics was also significantly reduced in the A-group (P<0.001). Both daily and cumulative opioid use was significantly reduced in the A-group (P<0.001). The time to first flatus and defecation was decreased in the A-group (P<0.001 and P=0.038, respectively). The incidence of PONV was significantly reduced from 26.0% to 12.5% after introduction of intravenous acetaminophen (P=0.017), and hospital stay tended to be decreased in the A-group (13.2 vs 14.7 days, P=0.069) Postoperative scheduled intravenous acetaminophen decreased opioid use and may be associated with enhanced recovery after gastrectomy.
UR - http://www.scopus.com/inward/record.url?scp=84995932409&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84995932409&partnerID=8YFLogxK
U2 - 10.1097/MD.0000000000005352
DO - 10.1097/MD.0000000000005352
M3 - Article
C2 - 27858921
AN - SCOPUS:84995932409
SN - 0025-7974
VL - 95
JO - Medicine (United States)
JF - Medicine (United States)
IS - 44
M1 - e5352
ER -